Actively Recruiting
Copenhagen Master Observational Trial
Led by Rigshospitalet, Denmark · Updated on 2025-07-24
2400
Participants Needed
1
Research Sites
334 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objectives of this prospective non-interventional study (NIS) are to assess and describe outcomes in relation to biomarkers, including whole-genome sequencing (WGS) in patients with non- small cell lung cancer (NSCLC) or breast cancer receiving treatment offered in the clinic (standard of care or included in clinical trials).
CONDITIONS
Official Title
Copenhagen Master Observational Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older with a diagnosis of NSCLC or breast cancer eligible for medical or radiation therapy with curative or palliative intent
- Signed and dated informed consent indicating the patient has been informed about the study
- Able to read and understand Danish
- Willing and able to participate in data collection including whole-genome sequencing
You will not qualify if you...
- Patients with breast cancer starting adjuvant systemic therapy
- Patients with a life expectancy fewer than 3 months at the time of NSCLC or breast cancer diagnosis as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rigshospitalet
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
U
Ulrik Lassen, MD
CONTACT
A
Andreas Bjerrum, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here